The 4 mg group lost 17.1%
Improvements in body composition (increased lean mass, reduced fat mass) have been observed in some research models and are cited in preclinical and clinical literature, though robust, large RCT data for aesthetic/bodybuilding uses are limited
It was built on years of investment to fully integrate clinical support with Nooms uniquely effective approach to behavior change, culminating in the September 2024 launch of Noom GLP1 Rx Program, our first-ever clinical weight loss plan to include GLP-1 medication (if prescribed), delivered to your door within 7 days, bundled with Nooms GLP-1 Companion app
These products are not for human consumption, nor are they intended to diagnose, treat, or cure any condition.
Hashimoto's patients in perimenopause Perimenopause adds another layer of complexity